Stoxline.com

Stoxline Lite

Stoxline Pro

Option Calculator
 

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations | Forex | Stock Talks | Blogs | Newsletter

 

Click to view technical analysis chart 

Free Download
Stoxline Android App

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

186.32

Shares Float (M)

168.29

% Held by Insiders

3.09

% Held by Institutions

84.60

Shares Short (K)

39660

Shares Short Prior Month (K)

40330

Stock Basics & Statistics

EPS

-1.490

EPS Est. Current Year

-1.080

EPS Est. Next Year

-0.700

EPS Est. Next Quarter

-0.290

Forward EPS

Book Value (p.s.)

PEG Ratio

-0.16

Profit Margin

Operating Margin

-589.90

Return on Assets (ttm)

-61.0

Return on Equity (ttm)

-183.8

Qtrly Rev. Growth

11187.8

Gross Profit (p.s.)

0.193

Sales Per Share

0.245

EBITDA (p.s.)

-1.420

Qtrly Earnings Growth

Operating Cash Flow (M)

-221.88

Levered Free Cash Flow (M)

-119.67

Valuation

P/E

-4.98

P/E Growth Ratio

-0.01

P/BV

7.42

P/S

30.34

P/CF

-6.23

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

Download Stock Research Reports

Subscribe to newsletters (free)

- Top Stock Picks, two picks per email. (one to three emails per week.)

- Weekly Showcase Stocks, two stocks per email. (one email per week.)

 

Enter Stock Symbol:  

Ariad Pharmaceuticals (ARIA)

7.445 -0.055 (-0.73%)

4/24/2014  2:26pm

Open:

7.62

Pre. Close:

7.50

High:

7.72

Low:

7.23

Volume:

5,165,655

Market Cap:

1.387B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.92 - 7.97

7.97 - 8.03

Low:

7.16 - 7.27

7.27 - 7.39

Close:

7.29 - 7.45

7.45 - 7.62

Technical analysis  (as of: 2014-04-24 2:19:30 PM)

Overall:

      

Our rating system posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 9.07     One year: 10.18

Support:

Support1: 6.23    Support2: 5.18

Resistance:

Resistance1: 7.77    Resistance2: 8.72

Pivot:

7.33

Moving Averages:

MA(5): 7.46     MA(20): 7.51

MA(100): 7.17     MA(250): 11.87

MACD:

MACD(12,26): -0.14     Signal(12,26,9): -0.18

%K %D:

%K(14,3): 57.33     %D(3): 53.38

RSI:

RSI(14): 47.82

52-Week:

High: 23.00  Low: 2.15  Change(%): -59.1

Average Vol(K):

3-Month: 14160  10-Days 9691

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ARIA has closed below upper band by 42.1%. Bollinger Bands are 49% narrower than normal. The narrow width of the bands suggests low volatility as compared to ARIA's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 02 Apr 2014 21:21:54 GMT
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?

Wed, 23 Apr 2014 11:26:15 GMT
Healthcare stocks' rally: Cytokinetics (CYTK), Ariad Pharmaceuticals, Inc ...

Thu, 24 Apr 2014 18:00:00 GMT
Stocks To Watch: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Allied Nevada ...

Thu, 24 Apr 2014 11:01:11 GMT
Biotech Active Runners: Illumina, Inc. (NASDAQ:ILMN), Ariad Pharmaceuticals ...

Mon, 07 Apr 2014 14:48:45 GMT
Is Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) A Market Mover?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

 

Nova Stocks

Share your ideas ...
Find hot stocks ...

 

(c) 2006-2013 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.